Gain Therapeutics Expects to Start Phase 2 Study During 3Q
Dow Jones Newswires
Gain Therapeutics Expects to Start Phase 2 Study During 3Q
- Sources
- Dow Jones Newswires
- Active symbols
- NASDAQ:GANX
- Language
- English
Gain Therapeutics Expects to Start Phase 2 Study During 3Q